The Case of Olympic Skater Kamila Valieva - Was CAS’s Decision Justified?
WADA to lodge appeal in case of Russian Olympic Committee figure skater
Key Amendments To The Hungarian Sports Act - Major Events, Anti-Doping & Agent Regulation
How could CrossFit’s anti-doping policy be strengthened?
The Anti-Doping Division of the Court Of Arbitration for Sport Responds To Wada
Statement from USADA CEO Travis T. Tygart on Eric Lira Investigation Conducted Under the Rodchenkov Anti-Doping Act
Sports Law in 2022 – Key issues to watch in Europe
Statement from USADA CEO Travis T. Tygart on Equine Anti-Doping and Medication Control Program Negotiations
Key Sports Law Cases And Developments Of 2021 – Asia, Africa & Oceania
Does the Shayna Jack CAS Appeal decision give hope to innocent athletes in contamination cases?
No Significant Fault: Andre Onana Returns After Falling Foul Of UEFA's Anti-Doping Regulations
UKAD quarterly results show increase compared to same time last year as testing ramps up pre-Beijing Winter Games
WADA Seeks Host for 2025 World Conference on Doping in Sport
On 24 November 2021, the World Anti-Doping Agency’s (WADA’s) Executive Committee agreed on a proposal from WADA Management to organize a Sixth World Conference on Doping in Sport in November 2025. Today, WADA is calling upon interested cities and countries that may be interested in hosting the Conference.
WADA Governance Review: a missed opportunity for urgently needed reform
Statement from the World Players Association:
The World Anti-Doping Agency (WADA) meets in Paris today and tomorrow and appears certain to once again avoid urgently needed governance reforms to address the escalating crisis facing the global anti-doping effort.
WADA publishes IOC Anti-Doping Rules for Beijing 2022 Winter Olympics
The World Anti-Doping Agency (WADA) has published the IOC Anti-Doping Rules applicable to the Beijing 2022 Winter Olympics.
A WADA statement said “The IOC, as the World Anti-Doping Code (Code) Signatory responsible for establishing the Rules applicable to the Games, has established and adopted these Rules to be in line with the 2021 Code and International Standards; most notably, the 2022 List of Prohibited Substances and Methods, which was published on 30 September 2021 and comes into force ahead of the Games on 1 January 2022. The Rules will cover the period from the opening of the Olympic Village on 27 January until the day of the closing ceremony on 20 February 2022.”
The ITA notifies German weightlifter Vicky Schlittig of an apparent anti-doping rule violation
THE INTERNATIONAL TESTING AGENCY (ITA), LEADING AN INDEPENDENT ANTI-DOPING PROGRAM FOR THE INTERNATIONAL WEIGHTLIFTING FEDERATION (IWF), HAS NOTIFIED GERMAN WEIGHTLIFTER VICKY SCHLITTIG OF AN APPARENT ANTI-DOPING RULE VIOLATION.
IWGA entrusts ITA with the independent anti-doping program for The World Games 2022 in Birmingham, Alabama
The International Testing Agency (ITA) is set to manage yet another independent and expert-led anti-doping program for a major event, after completing its missions for the Olympic Games in Tokyo in 2020 and the upcoming Olympic Winter Games in Beijing in 2022. The International World Games Association (IWGA) has entered a collaboration with the ITA for its next major event, The World Games 2022, to be held in July in Birmingham, Alabama (USA).
Anti-Doping Forum Hosted by ONDCP with Olympic and Paralympic Athletes, Sponsors, and Other Stakeholders
The United States Olympic and Paralympic Committee Athletes’ Advisory Council (AAC) and the U.S. Anti-Doping Agency (USADA) are honored to have been invited to the first-ever ONDCP anti-doping forum including Olympic and Paralympic athletes, the USOPC, AAC, USADA, and U.S. corporate sponsors held on Friday, November 12, 2021.
Managing TUEs during the Olympic Winter Games Beijing 2022 – A guide for athletes
WADA announces Independent Observer teams for Beijing Olympic and Paralympic Games
The World Anti-Doping Agency (WADA) is pleased to announce its Independent Observer (IO) program teams for the Winter Olympic and Paralympic Games in Beijing, China, which will take place from 4-20 February and from 4-13 March 2022, respectively.
WADA’s IO program, which has been running since the 2000 Olympic Games in Sydney, Australia, and has included more than 50 major events during that time, is an important element of WADA’s compliance monitoring of Major Event Organizations. The IO teams provide an independent review of all aspects of the anti-doping programs as delivered at major events, including the Olympic and Paralympic Games.
WADA releases new e-learning course for athletes and coaches heading to Beijing 2022 Paralympic Winter Games
The World Anti-Doping Agency (WADA) has launched a new education course on its Anti-Doping Education and Learning platform (ADEL), specifically designed for athletes (including their guides) and coaches aiming to attend the Beijing 2022 Paralympic Winter Games.
Powerlifting Athlete Suspended for the Presence and Use of Tamoxifen
The Canadian Centre for Ethics in Sport (CCES) announced today that Phillipe Marcil, a powerlifting athlete, received a two-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on August 21, 2021, revealed the presence of tamoxifen, a prohibited hormone and metabolic modulator.
Statement from USADA CEO Travis T. Tygart on HISA Introduction of Equine Protocol, Prohibited List, and Definitions
“We are honored to be involved at this stage to help draft and ultimately finalize gold-standard rules on anti-doping and medication control for the equine industry. We are excited with where this process is headed and with proposed rules being published for two additional rounds of public feedback.”
WADA publishes updated Therapeutic Use Exemption Physician Guidelines and Checklists reflecting changes concerning injectable glucocorticoids
The World Anti-Doping Agency (WADA) is pleased to publish the following updated Therapeutic Use Exemption (TUE) Physician Guidelines and Checklists, which reflect the latest rule changes regarding injectable routes of administration of glucocorticoids (GCs) coming into force on 1 January 2022 under the 2022 List of Prohibited Substances and Methods (List).
WADA publishes 2020 Annual Report under the theme ‘Partnering to Deliver Clean Sport in a New Era’
Today, the World Anti-Doping Agency (WADA) published its 2020 Annual Report, which outlines the Agency’s activities in 2020 that contributed to a strengthened WADA and global anti-doping system. Under the title ‘Partnering to Deliver Clean Sport in a New Era’, the Annual Report is an important element of WADA’s ongoing commitment to accountability and transparency.
UKAD and CGF to spearhead Commonwealth Games Anti-Doping Taskforce
U.S. Weightlifting Coaches Ernest Prempeh and Bernabe Chavez Accept Sanctions for Anti-Doping Rule Violation
U.S. Weightlifting Athlete Ian Wilson Accepts Sanction for Anti-Doping Rule Violation
Milestone 100,000 samples collected by UKAD
CAS Bulletin 2022
Former rugby league player Jamie Acton banned for two years, following sample re-analysis
A Summary Of 2021’s Key Sports Law Cases From The CAS & SFT
Key Sports Law Cases & Developments Of 2021 – Europe
U.S. Ice Hockey Athlete Grace Bowlby Accepts Public Warning
U.S. Paralympic Judo Athlete Trey Lampkin Accepts Public Warning
U.S. Triathlon Athlete Noah Webb Accepts Sanction for Anti-Doping Rule Violation
USADA announced today that Noah Webb, of Los Angeles, Calif., an athlete in the sport of triathlon, has accepted a four-year period of ineligibility for an anti-doping rule violation.
Webb, 48, tested positive an anabolic agent as the result of an in-competition urine sample collected at the Toyota USA Triathlon Age Group Olympic National Championships on August 7, 2021. His urine sample was analyzed using a specialized test known as Isotope Ratio Mass Spectrometry (IRMS), which is capable of measuring the carbon isotope ratio of urinary steroids and confirming their synthetic origin—in this case, testosterone or its precursors. IRMS is a powerful tool that unequivocally differentiates between anabolic androgenic steroids (AAS) naturally produced by the body and AAS of synthetic origin. Anabolic agents like testosterone have powerful performance-enhancing capabilities and can give an athlete an unfair advantage over fellow competitors.
U.S. Weightlifting Athlete Jordan Adel Accepts Sanction for Anti-Doping Rule Violation
The ITA asserts an Anti-Doping Rule Violation against Russian weightlifter Kseniya Kozina
The International Testing Agency (ITA), leading an independent anti-doping program for the International Weightlifting Federation (IWF), asserts an anti-doping rule violation (ADRV) against Russian weightlifter Kseniya Kozina for the use of prohibited substances based on data retrieved by the World Anti-Doping Agency (WADA) from the Moscow Laboratory
WADA Foundation Board unanimously approves further governance reforms
- Approval of Independent Ethics Board; additional seats on Executive Committee for an athlete representative and an independent member, and on Foundation Board for athletes and National Anti-Doping Organizations; and establishment of WADA Athletes’ Council
- Athletes’ Anti-Doping Ombuds Program to be piloted next year
- New Confidential Sources’ Policy approved
WADA posts IOC’s Anti-Doping Rules for Beijing 2022 Games
At the request of the International Olympic Committee (IOC), and as was the case for previous Olympic Games, the World Anti-Doping Agency (WADA) posts the IOC’s Anti-Doping Rules (Rules) and accompanying circular letter applicable to the Olympic Games Beijing 2022 (2022 Games) taking place in February 2022.
WADA co-edits book on emerging drugs in sport
The World Anti-Doping Agency (WADA) is proud to announce the publication today of a new book, “Emerging Drugs in Sport”, that was co-edited by WADA’s Senior Director of Science and Medicine, Dr. Olivier Rabin.
The book is the first of its kind on the use of Novel Psychoactive Substances (NPS)* in sports and features contributions by multidisciplinary leading experts in the field. Co-edited in collaboration with Professor Ornella Corazza, Associate Professor in Substance Addiction and Behaviours at the University of Hertfordshire in the United Kingdom and a leading scholar in the field of Novel Psychoactive Substances, the book provides the latest findings on anti-doping including anti-doping techniques, regulation, policy and market structure of NPS used in sports.
The ITA publishes the first-ever NOC Anti-Doping Education Guidebook
The resource was designed by the ITA to support all National Olympic Committees taking part in the Olympic Winter Games Beijing 2022 with the Anti-Doping Education of their athletes and athlete support personnel ahead of the games.
WADA extends analytical testing restriction imposed on the Bucharest Laboratory
The World Anti-Doping Agency (WADA) has extended the analytical testing restriction (ATR) imposed on the Romanian Doping Control Laboratory in Bucharest (Bucharest Laboratory). The ATR, related to the Gas Chromatography / Combustion / Isotope Ratio Mass Spectrometry (GC/C/IRMS) analytical method, was originally imposed in 1 May 2021 for a period of up to six months.
Sport Integrity Australia: weightlifter receives sanction
Sport Integrity Australia acknowledges the decision of the Australian Weightlifting Federation to sanction athlete Nathan Mortensen for the presence of prohibited substances and their metabolites and the use and possession of prohibited substances.
Mr Mortensen returned an Adverse Analytical Finding (AAF) from an out-of-competition doping control test on 10 September 2020.
Iranian athlete Nikoeimajd Mehran suspended four years for anti-doping rule violation
The International Paralympic Committee (IPC) has suspended Iranian Para athletics athlete Nikoeimajd Mehran for a period of four years for committing an anti-doping rule violation (ADRV).
The athlete was found to have committed an ADRV pursuant to IPC Anti-Doping Code Article 2.2 of the IF Rules: Use or Attempted Use by an Athlete of a Prohibited Substance or a Prohibited Method.
Introduction to Equine Protocol, Prohibited List, and Definitions
WADA Strategic Testing Expert Advisory Group explores alternative sample collection programs
From 27-29 September 2021, the World Anti-Doping Agency’s (WADA’s) Strategic Testing Expert Advisory Group held three virtual meetings focused on the following topics:
- An overview of new and existing areas of testing, including the implementation of Dried Blood Spot (DBS) and sample collection best practices for transgender athletes;
- A review and update of the ‘Guidance for Testing during COVID-19 Pandemic’ document which was issued in November 2020;
- A review of the implementation of, and compliance with, the Technical Document for Sports Specific Analysis (TDSSA), including the implementation of the haematological module of the Athlete Biological Passport (ABP); and
- The progress of a feasibility study on alternative sample collection programs.
WADA invites stakeholders to the eighth International Conference on Novel Psychoactive Substances
The World Anti-Doping Agency (WADA) is pleased to invite stakeholders to the eighth International Conference on Novel Psychoactive Substances (NPS). The event, which will take place virtually from 17-19 November 2021, is jointly organized by WADA, the United Nations Office on Drugs and Crime (UNODC), the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the International Society for the Study of Emerging Drugs (ISSED), the University of Hertfordshire, and the Centre for Forensic Science Research and Education (CFSRE).
ITA Webinar – The Prohibited List & TUEs – Overview and Changes for 2022
REGISTER HERE
The Prohibited List is one of the most important anti-doping documents that athletes and athlete support personnel need to be aware of, and to understand. But what is it, and how is it best navigated? And how can Therapeutic Use Exemptions grant permission to use a medication on the Prohibited List?
WADA’s Therapeutic Use Exemption program – providing inclusion and fairness for athletes
In this latest edition of ‘Spotlight’, which keeps stakeholders up to date on the activities being carried out by the World Anti-Doping Agency (WADA) team and its partners, we look at the Therapeutic Use Exemption (TUE) program. This program provides a harmonized global approach for athletes that have illnesses or medical conditions that require them to take medications that are included on WADA’s Prohibited List. Previous ‘Spotlight’ features are available on WADA’s website.
